Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS®) Device
Helius Medical Technologies, Inc. Announces Exploration of Strategic Alternatives
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference
Helius Medical Technologies, Inc. (NASDAQ: HSDT) had its "hold" rating re-affirmed by analysts at Maxim Group.
Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece [Financial Post (Toronto, Ontario, Canada)]